Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors.: Part 2:: Parallel synthesis, molecular modelling and structure-activity relationship studies on analogues of O-(2-phenylethyl)-N-phenylthiocarbamate

被引:12
作者
Cesarini, Sara [1 ]
Spallarossa, Andrea [1 ]
Ranise, Angelo [1 ]
Bruno, Olga [1 ]
La Colla, Paolo [2 ]
Secci, Barbara [2 ]
Collu, Gabriella [2 ]
Loddo, Roberta [2 ]
机构
[1] Univ Genoa, Dipartimento Sci Farmaceut, I-16132 Genoa, Italy
[2] Univ Cagliari, Dipartimento Sci & Technol Biomed, I-09042 Cagliari, Italy
关键词
thiocarbamates; HIV-1; non-nucleoside reverse transcriptase inhibitors; parallel synthesis;
D O I
10.1016/j.bmc.2007.12.046
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To acquire further insight into the structure-activity relationship (SAR) of the thiocarbamates (TCs) described in the preceding work, 57 analogues of the lead compound O-(2-phenylethyl)-N-phenylthiocarbamate I were prepared by parallel solution-phase synthesis. We varied the 2-phenylethyl moiety (mono-substitution on the phenyl ring and modi. cation of the ethyl linker), keeping constant the N-phenyl ring substitutions which have given the best results in the previous series. Most of the new TCs inhibited wild-type HIV-1 at micro-and nanomolar concentrations in MT-4 cell-based assays. Some TCs were also active at micromolar concentrations against the Y181C and/or K103N/Y181C resistant mutants. The SARs were rationalized by docking simulations. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4173 / 4185
页数:13
相关论文
共 26 条
[1]   THE PETT SERIES, A NEW CLASS OF POTENT NONNUCLEOSIDE INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE [J].
AHGREN, C ;
BACKRO, K ;
BELL, FW ;
CANTRELL, AS ;
CLEMENS, M ;
COLACINO, JM ;
DEETER, JB ;
ENGELHARDT, JA ;
HOGBERG, M ;
JASKUNAS, SR ;
JOHANSSON, NG ;
JORDAN, CL ;
KASHER, JS ;
KINNICK, MD ;
LIND, P ;
LOPEZ, C ;
MORIN, JM ;
MUESING, MA ;
NOREEN, R ;
OBERG, B ;
PAGET, CJ ;
PALKOWITZ, JA ;
PARRISH, CA ;
PRANC, P ;
RIPPY, MK ;
RYDERGARD, C ;
SAHLBERG, C ;
SWANSON, S ;
TERNANSKY, RJ ;
UNGE, T ;
VASILEFF, RT ;
VRANG, L ;
WEST, SJ ;
ZHANG, H ;
XHOU, XX .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1329-1335
[2]   PHENETHYLTHIAZOLETHIOUREA (PETT) COMPOUNDS, A NEW CLASS OF HIV-1 REVERSE-TRANSCRIPTASE INHIBITORS .1. SYNTHESIS AND BASIC STRUCTURE-ACTIVITY RELATIONSHIP STUDIES OF PETT ANALOGS [J].
BELL, FW ;
CANTRELL, AS ;
HOGBERG, M ;
JASKUNAS, SR ;
JOHANSSON, NG ;
JORDAN, CL ;
KINNICK, MD ;
LIND, P ;
MORIN, JM ;
NOREEN, R ;
OBERG, B ;
PALKOWITZ, JA ;
PARRISH, CA ;
PRANC, P ;
SAHLBERG, C ;
TERNANSKY, RJ ;
VASILEFF, RT ;
VRANG, L ;
WEST, SJ ;
ZHANG, H ;
ZHOU, XX .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (25) :4929-4936
[3]   Non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis and biological evaluation of novel quinoxalinylethylpyridylthioureas as potent antiviral agents [J].
Campiani, G ;
Fabbrini, M ;
Morelli, E ;
Nacci, V ;
Greco, G ;
Novellino, E ;
Maga, G ;
Spadari, S ;
Bergamini, A ;
Faggioli, E ;
Uccella, I ;
Bolacchi, F ;
Marini, S ;
Coletta, M ;
Fracasso, C ;
Caccia, S .
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 2000, 11 (02) :141-155
[4]   Phenethylthiazolylthiourea (PETT) compounds as a new class of HIV-1 reverse transcriptase inhibitors .2. Synthesis and further structure-activity relationship studies of PETT analogs [J].
Cantrell, AS ;
Engelhardt, P ;
Hogberg, M ;
Jaskunas, SR ;
Johansson, NG ;
Jordan, CL ;
Kangasmetsa, J ;
Kinnick, MD ;
Lind, P ;
Morin, JM ;
Muesing, MA ;
Noreen, R ;
Oberg, B ;
Pranc, P ;
Sahlberg, C ;
Ternansky, RJ ;
Vasileff, RT ;
Vrang, L ;
West, SJ ;
Zhang, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (21) :4261-4274
[5]   Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors.: Part 1:: Parallel synthesis, molecular modelling and structure-activity relationship studies on O-[2-(hetero)arylethyl]-N-phenylthiocarbamates [J].
Cesarini, Sara ;
Spallarossa, Andrea ;
Ranise, Angelo ;
Fossa, Paola ;
La Colla, Paolo ;
Sanna, Giuseppina ;
Collu, Gabriella ;
Loddo, Roberta .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (07) :4160-4172
[6]   Dawn of non-nucleoside inhibitor-based anti-HIV microbicides [J].
D'Cruz, OJ ;
Uckun, FM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (03) :411-423
[7]   Novel tight binding PETT, HEPT and DABO-based non-nucleoside inhibitors of HIV-1 reverse transcriptase [J].
D'Cruz, Osmond J. ;
Uckun, Fatih M. .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2006, 21 (04) :329-350
[8]   Novel broad-spectrum thiourea non-nucleoside inhibitors for the prevention of mucosal HIV transmission [J].
D'Cruz, Osmond J. ;
Uckun, Fatih M. .
CURRENT HIV RESEARCH, 2006, 4 (03) :329-345
[9]   Antioxidant function of phenethyl-5-bromo-pyridyl thiourea compounds with potent anti-HIV activity [J].
Dong, YH ;
Venkatachalam, TK ;
Narla, RK ;
Trieu, VN ;
Sudbeck, EA ;
Uckun, FM .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (01) :87-90
[10]   An extensively modified version of MolScript that includes greatly enhanced coloring capabilities [J].
Esnouf, RM .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 1997, 15 (02) :132-+